Electrochemotherapy of melanoma cutaneous metastases;Melanoma-bo″ráttétek elektrokemoterápiája

Orvosi Hetilap

Volumn 151, Issue 3, 2010, Pages 96-101

  Kis, Erika ^a   Szegesdi, Ilona ^b   Ocsai, Henriette ^a   Gyulai, Rolland ^a   Kemény, Lajos ^a   Oláh, Judit ^c  

^a Borgyógyászati És Allergológiai KlinikaKorányi ^*  (Hungary)

^b Klinikai Kozpont Aneszteziologiai Es Intenziv Terapias Intezet   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Bleomycin; Cutaneous and subcutaneous melanoma; Electrochemotherapy; Metastasis

Indexed keywords

BLEOMYCIN; ANTINEOPLASTIC ANTIBIOTIC;

ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; ELECTROCHEMOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MALE; MELANOMA; OUTCOME ASSESSMENT; QUALITY OF LIFE; SKIN METASTASIS; DISEASE COURSE; GENERAL ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REMISSION; SKIN TUMOR; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANESTHESIA, GENERAL; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; DISEASE PROGRESSION; ELECTROCHEMOTHERAPY; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MELANOMA; MIDDLE AGED; REMISSION INDUCTION; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 75449119697     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2010.28781     Document Type: Article

References (35)

1. Mir, L. M.: Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry, 2001, 53, 1-10.
2. Miklavcic, D., Corovic, S., Pucihar, G. és mtsai: Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. Eur. J. Cancer, 2006, 4, 45-51.
3. Miklavcic, D., Semrov, D., Mekid, H. és mtsai: A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim. Biophys. Acta, 2000, 1523, 73-83.
4. Pucihar, G., Kotnik, T., Valic, B. és mtsai: Numerical determination of transmembrane voltage induced on irregularly shaped cells. Ann. Biomed. Eng., 2006, 34, 642-652.
5. Mir, L. M.: Bases and rationale of the electrochemotherapy. Eur. J. Cancer, 2006, 4, 38-44.
6. Orlowski, S., Belehradek, J. Jr., Paoletti, C. és mtsai: Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem. Pharmacol., 1988, 37, 4727-4733.
7. Sersa, G., Cemazar, M., Miklavcic, D.: Antitumor effectiveness of electrochemotherapy with cis-diammine dichloro pla ti num(II) in mice. Cancer Res., 1995, 55, 3450-3455.
8. Mir, L. M., Gehl, J., Sersa, G. és mtsai: Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator (TM) by means of invasive or non-invasive electrodes. Eur. J. Cancer, 2006, 4, 14-25.
9. Sersa, G.: The state-of-the-art of electrochemotherapy before the ESOPE study; advantages and clinical uses. Eur. J. Cancer, 2006, 4, 52-59.
10. Byrne, C. M., Thompson, J. F.: Role of electrochemotherapy in the treatment of metastatic melanoma and other metastatic and primary skin tumors. Expert. Rev. Anticancer Ther., 2006, 6, 671-678.
11. Mir, L. M., Glass, L. F., Sersa, G. és mtsai: Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br. J. Cancer, 1998, 77, 2336-2342.
12. Heller, R., Jaroszeski, M., Perrott, R. és mtsai: Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res., 1997, 7, 10-18.
13. Sersa, G., Stabuc, B., Cemazar, M. és mtsai: Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin. Cancer Res., 2000, 6, 863-867.
14. Bloom, D. C., Goldfarb, P. M.: The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck. Eur. J. Surg. Oncol., 2005, 31, 1029-1035.
15. Byrne, C. M., Thompson, J. F., Johnston, H. és mtsai: Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy). Melanoma Res., 2005, 15, 45-51.
16. Marty, M., Sersa, G., Garbay, J. R. és mtsai: Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur. J. Cancer, 2006, 4, 3-13.
17. Domenge, C., Orlowski, S., Luboinski, B. és mtsai: Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer, 1996, 77, 956-963.
18. WHO: Handbook for reporting results of cancer treatment. 1997, 22-27.
19. Campana, L. G., Mocellin, S., Basso, M. és mtsai: Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann. Surg. Oncol., 2009, 16, 191-199.
20. Snoj, M., Rudolf, Z., Paulin-Kosir, S. M. és mtsai: Long lasting complete response in melanoma treated by electrochemotherapy. Eur. J. Cancer, 2006, 4, 26-28.
21. Quaglino, P., Mortera, C., Osella-Abate, S. és mtsai: Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann. Surg. Oncol., 2008, 15, 2215-2222.
22. Cemazar, M., Milacic, R., Miklavcic, D. és mtsai: Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content. Anticancer Drugs, 1998, 9, 525-530.
23. Puc, M., Corovic, S., Flisar, K. és mtsai: Techniques of signal generation required for electropermeabilization. Survey of electropermeabilization devices. Bioelectrochemistry, 2004, 64, 113-124.
24. Mir, L. M., Orlowski, S., Belehradek, J. Jr. és mtsai: Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer, 1991, 27, 68-72.
25. Belehradek, J. Jr., Orlowski, S., Poddevin, B. és mtsai: Electrochemotherapy of spontaneous mammary tumours in mice. Eur. J. Cancer, 1991, 27, 73-76.
26. Snoj, M., Rudolf, Z., Cemazar, M. és mtsai: Successful sphinctersaving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. Anticancer Drugs, 2005, 16, 345-348.
27. Shimizu, T., Nikaido, T., Gomyo, H. és mtsai: Electrochemotherapy for digital chondrosarcoma. J. Orthop. Sci., 2003, 8, 248-251.
28. Glass, L. F., Pepine, M. L., Fenske, N. A. és mtsai: Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch. Dermatol., 1996, 132, 1353-1357.
29. Gaudy, C., Richard, M. A., Folchetti, G. és mtsai: Randomized controlled study of electrochemotherapy in the local treatment of skin metastases of melanoma. J. Cutan. Med. Surg., 2006, 10, 115-121.
30. Pavselj, N., Bregar, Z., Cukjati, D. és mtsai: The course of tissue permeabilization studied on a mathematical model of a subcutaneous tumor in small animals. IEEE Trans. Biomed. Eng., 2005, 52, 1373-1381.
31. Colombo, G. L., Matteo, S. D., Mir, L. M.: Cost-effectiveness analysis of electrochemotherapy with the Cliniporatortrade mark vs other methods for the control and treatment of cutaneous and subcutaneous tumors. Ther. Clin. Risk Manag., 2008, 4, 541-548.
32. Snoj, M., Cemazar, M., Slekovec, K. B. és mtsai: Effective treatment of multiple unresectable skin melanoma metastases by electrochemotherapy. Croat. Med. J., 2007, 48, 391-395.
33. Glass, L. F., Fenske, N. A., Jaroszeski, M. és mtsai: Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J. Am. Acad. Dermatol., 1996, 34, 82-86.
34. Rols, M. P., Bachaud, J. M., Giraud, P. és mtsai: Electrochemotherapy of cutaneous metastases in malignant melanoma. Melanoma Res., 2000, 10, 468-474.
35. Heller, R., Jaroszeski, M. J., Reintgen, D. S. és mtsai: Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer, 1998, 83, 148-157. (Pubitemid 28299641)